Tag: Prescription Drugs
Rate of Approval for PCSK9i Therapy 47 Percent
Clinical factors and payer type linked to likelihood of approval, with highest approval for Medicare
Gifts From Pharma Companies Influence Prescribing Behavior
Clinicians who receive gifts write more prescriptions per patient, more costly and branded prescriptions
Secondary Prevention Meds Often Not Started Post-AMI in Seniors
More than a third of older nursing home residents did not start medication after myocardial infarction
Tofogliflozin Most Effective With High Baseline Insulin
These patients have largest improvements in fasting plasma glucose level, insulin secretion index
DEA Taking Back Unwanted Prescription Drugs on Oct. 28
Only pills or patches will be accepted, not liquids, needles, or sharps; service is free and anonymous
Medicaid’s Best-Price Rule May Not Be Such a Big Problem
There are ways to avoid or mitigate impact of the rule, though it may affect novel pricing strategies
Independent Pharmacies Adding Patient Care Services, Products
Change is a response to low net margins on drugs; number of community pharmacies has fallen slightly
Tofacitinib Superior to Placebo in Active Psoriatic Arthritis
Tofacitinib is superior for patients with inadequate response to TNF inhibitors or conventional DMARDs
Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes
Phase 3 studies next to assess longer-term/clinical outcomes, safety
No Increased Risks for DOAC Use Versus Warfarin in VTE
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism
